Understanding loss of donor white blood cell immunogenicity after pathogen reduction: Mechanisms of action in ultraviolet illumination and riboflavin treatment

Transfusion

Volumn 49, Issue 12, 2009, Pages 2686-2699

  Jackman, Rachael P ^a,b   Heitman, John W ^a,b   Marschner, Susanne ^a,b   Goodrich, Raymond P ^a,b   Norris, Philip J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CaridianBCT Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CELL ADHESION MOLECULE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; RIBOFLAVIN; STAT PROTEIN;

ANTIGEN PRESENTING CELL; ARTICLE; BLOOD DONOR; CELL ADHESION; CELL CONTACT; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; ILLUMINATION; IMMUNOGENICITY; LEUKOCYTE; MICROBIOLOGICAL PARAMETERS; PATHOGEN REDUCTION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; T LYMPHOCYTE ACTIVATION; TECHNOLOGY; ULTRAVIOLET RADIATION;

BLOOD PRESERVATION; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CELL ADHESION MOLECULES; CELL DEATH; CELL DIVISION; CELL SURVIVAL; FLOW CYTOMETRY; HLA ANTIGENS; HUMANS; ISOANTIGENS; LEUKOCYTES; LYMPHOCYTE ACTIVATION; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 71849084205     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02333.x     Document Type: Article

References (52)

1. Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006 35 : 5 17.
2. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006 90 : 85 91.
3. Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007 37 : 131 7.
4. Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007 47 : 240 7.
5. Fast LD, Dileone G, Li J, Goodrich R. Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006 46 : 642 8.
6. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 9.
7. Blundell EL, Pamphilon DH, Fraser ID, Menitove JE, Greenwalt TJ, Snyder EL, Repucci AJ, Hedberg SL, Anderson JK, Buchholz DH, Kagen LR, Aster RH. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy. Transfusion 1996 36 : 296 302.
8. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005 105 : 4106 14.
9. Ullrich SE. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005 571 : 185 205.
10. Leitenberger J, Jacobe HT, Cruz PD Jr. Photoimmunology - illuminating the immune system through photobiology. Semin Immunopathol 2007 29 : 65 70.
11. Babic AM. Extracorporeal photopheresis: lighting the way to immunomodulation. Am J Hematol 2008 83 : 589 91.
12. Knobler R. Extracorporeal photochemotherapy - present and future. Vox Sang 2000 78 Suppl 2 : 197 201.
13. Oliven A, Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 2001 15 : 103 8.
14. Russo GG, Mullen C. Cutaneous and noncutaneous disorders treated with extracorporeal photopheresis. Int J Dermatol 2001 40 : 89 100.
15. Jakway JP, Shevach EM. Stimulation of T-cell activation by UV-treated, antigen-pulsed macrophages: evidence for a requirement for antigen processing and interleukin 1 secretion. Cell Immunol 1983 80 : 151 62.
16. Lindahl-Kiessling K, Safwenberg J. Inability of UV-irradiated lymphocytes to stimulate allogeneic cells in mixed lymphocyte culture. Int Arch Allergy Appl Immunol 1971 41 : 670 8.
17. Rich EA, Elmets CA, Fujiwara H, Wallis RS, Ellner JJ. Deleterious effect of ultraviolet-B radiation on accessory function of human blood adherent mononuclear cells. Clin Exp Immunol 1987 70 : 116 26.
18. Deeg HJ, Sigaroudinia M. Ultraviolet B-induced loss of HLA class II antigen expression on lymphocytes is dose, time, and locus dependent. Exp Hematol 1990 18 : 916 9.
19. Fujihara M, Takahashi TA, Azuma M, Ogiso C, Maekawa TL, Yagita H, Okumura K, Sekiguchi S. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity. Blood 1996 87 : 2386 93.
20. Hanlon DJ, Berger CL, Edelson RL. Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes. Int J Cancer 1998 78 : 70 5.
21. Young JW, Baggers J, Soergel SA. High-dose UV-B radiation alters human dendritic cell costimulatory activity but does not allow dendritic cells to tolerize T lymphocytes to alloantigen in vitro. Blood 1993 81 : 2987 97.
22. De Luca DJ, Trefzer U, Tubesing KA, Elmets CA. ICAM-1 mRNA levels and relative transcription rates are decreased by UV irradiation of monocytes. Photochem Photobiol 1997 65 : 609 15.
23. Kobata T, Ikeda H, Ohnishi Y, Urushibara N, Nakata SO, Takahashi TA, Sekiguchi S. Ultraviolet irradiation inhibits killer-target cell interaction. Vox Sang 1993 65 : 25 31.
24. Krutmann J, Czech W, Parlow F, Trefzer U, Kapp A, Schopf E, Luger TA. Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine-induced ICAM-1 mRNA expression is transient, differentially restored for IFN gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathway. J Invest Dermatol 1992 98 : 923 8.
25. Krutmann J, Khan IU, Wallis RS, Zhang F, Rich EA, Ellner JJ, Elmets CA. Cell membrane is a major locus for ultraviolet B-induced alterations in accessory cells. J Clin Invest 1990 85 : 1529 36.
26. Krutmann J, Trefzer U. Modulation of the expression of intercellular adhesion molecule-1 (ICAM-1) in human keratinocytes by ultraviolet (UV) radiation. Springer Semin Immunopathol 1992 13 : 333 44.
27. Meineke V, Moede T, Gilbertz KP, Mayerhofer A, Ring J, Kohn FM, Van Beuningen D. Protein kinase inhibitors modulate time-dependent effects of UV and ionizing irradiation on ICAM-1 expression on human hepatoma cells. Int J Radiat Biol 2002 78 : 577 83.
28. Maekawa TL, Takahashi TA, Fujihara M, Akasaka J, Fujikawa S, Minami M, Sekiguchi S. Effects of ultraviolet B irradiation on cell-cell interaction; implication of morphological changes and actin filaments in irradiated cells. Clin Exp Immunol 1996 105 : 389 96.
29. Legitimo A, Consolini R, Di Stefano R, Bencivelli W, Mosca F. Psoralen and UVA light: an in vitro investigation of multiple immunological mechanisms underlying the immunosuppression induction in allograft rejection. Blood Cells Mol Dis 2002 29 : 24 34.
30. Tronnier M, Alexander M, Wolff HH. Adhesion molecule expression in normal skin and melanocytic lesions. Role of UV-irradiation and architectural characteristics in nevi. J Cutan Pathol 1997 24 : 278 85.
31. Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, Ravanat JL, Cadet J, Goodrich RP. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004 80 : 15 21.
32. Martin CB, Wilfong E, Ruane P, Goodrich R, Platz M. An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage. Photochem Photobiol 2005 81 : 474 80.
33. Li J, Lockerbie O, de Korte D, Rice J, McLean R, Goodrich RP. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion 2005 45 : 920 6.
34. Morigaki K, Kiyosue K, Taguchi T. Micropatterned composite membranes of polymerized and fluid lipid bilayers. Langmuir 2004 20 : 7729 35.
35. Okazaki T, Inaba T, Tatsu Y, Tero R, Urisu T, Morigaki K. Polymerized lipid bilayers on a solid substrate: morphologies and obstruction of lateral diffusion. Langmuir 2009 25 : 345 51.
36. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse: a molecular machine controlling T cell activation. Science 1999 285 : 221 7. (Pubitemid 29329988)
37. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990 11 : 211 6.
38. Devary Y, Gottlieb RA, Lau LF, Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 1991 11 : 2804 11.
39. Devary Y, Gottlieb RA, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992 71 : 1081 91.
40. Ichiki H, Sakurada H, Kamo N, Takahashi TA, Sekiguchi S. Generation of active oxygens, cell deformation and membrane potential changes upon UV-B irradiation in human blood cells. Biol Pharm Bull 1994 17 : 1065 9.
41. Devary Y, Rosette C, DiDonato JA, Karin M. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 1993 261 : 1442 5.
42. Simon MM, Aragane Y, Schwarz A, Luger TA, Schwarz T. UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J Invest Dermatol 1994 102 : 422 7.
43. Grass JA, Hei DJ, Metchette K, Cimino GD, Wiesehahn GP, Corash L, Lin L. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood 1998 91 : 2180 8. (Pubitemid 28185525)
44. Grass JA, Wafa T, Reames A, Wages D, Corash L, Ferrara JL, Lin L. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999 93 : 3140 7.
45. Rebulla P, Bertolini F, Parravicini A, Sirchia G. Leukocyte-poor blood components: a purer and safer transfusion product for recipients? Transfus Med Rev 1990 4 : 19 23.
46. Akahoshi M, Takanashi M, Masuda M, Yamashita H, Hidano A, Hasegawa K, Kasajima T, Shimizu M, Motoji T, Oshimi K, Mizoguchi H. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 1992 32 : 169 72.
47. Hayashi H, Nishiuchi T, Tamura H, Takeda K. Transfusion-associated graft-versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology 1993 79 : 1419 21.
48. Williamson LM, Stainsby D, Jones H, Love E, Chapman CE, Navarrete C, Lucas G, Beatty C, Casbard A, Cohen H. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease. Transfusion 2007 47 : 1455 67.
49. Reed W, Lee TH, Norris PJ, Utter GH, Busch MP. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin Hematol 2007 44 : 24 31.
50. Luban NL, Drothler D, Moroff G, Quinones R. Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion 2000 40 : 348 52.
51. Pelszynski MM, Moroff G, Luban NL, Taylor BJ, Quinones RR. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994 83 : 1683 9.
52. Lee TH, Reed W, Mangawang-Montalvo L, Watson J, Busch MP. Donor WBCs can persist and transiently mediate immunologic function in a murine transfusion model: effects of irradiation, storage, and histocompatibility. Transfusion 2001 41 : 637 42.